Evidence map›Paper›PMID 32046318›Full record

ArticleCancers2020

PSA and PSA Kinetics Thresholds for the Presence of

Manuela Andrea Hoffmann, Hans-Georg Buchholz, Helmut J Wieler, Matthias Miederer, Florian Rosar, Nicolas Fischer, Jonas Müller-Hübenthal, Ludwin Trampert, Stefanie Pektor, Mathias Schreckenberger

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Comparison of [Cancers · 2022
    Article
  9. Diagnostic Performance and Clinical Impact ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  10. Article
  11. Cancers · 2022
    Article
  12. Article
  13. [European journal of nuclear medicine and molecular imaging · 2021
    Article
  14. Dual-Time Point [Cancers · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Manuela Andrea HoffmannDepartment of Occupational Health & Safety, Federal Ministry of Defense, 53123 Bonn, Germany.
Hans-Georg BuchholzClinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
Helmut J WielerClinic of Nuclear Medicine, Bundeswehr Central Hospital, 56072 Koblenz, Germany.
Matthias MiedererClinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
Florian RosarClinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
Nicolas FischerDepartment of Urology, Helios Kliniken Krefeld, 47805 Krefeld, Germany.
Jonas Müller-HübenthalPractice of Radiology and Nuclear Medicine, Praxis im KölnTriangle, 50679 Köln, Germany.
Ludwin TrampertClinic of Nuclear Medicine, Klinikum Mutterhaus der Borromäerinnen, 54290 Trier, Germany.
Stefanie PektorClinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
Mathias SchreckenbergerClinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
Johannes Gutenberg University Mainz · DEBundeswehrzentralkrankenhaus Koblenz · DEFederal Ministry of Defence · DEHelios Klinikum Krefeld · DEKlinikum Mutterhaus der Borromäerinnen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

68Gallium-PSMA PET/CTbiochemical recurrenceoptimal cutoff levelprostate cancerprostate-specific-antigenPSA kinetics thresholds

Identifiers

PMID32046318
PMCPMC7072299
OpenAlexW3005385207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.